Perceptions of Dermatologic AEs Could Impact Treatment Adherence
A survey found that patients believed dermatologic AEs were more prevalent with anti-cancer therapies than what has been reported.
Previous Post
Gilead dives into ‘in vivo’ cell therapy with $350M buyout of Interius
Next Post
CDC advisory panel member no longer trusts CDC
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago